Investor Presentaiton
US Business at a glance
5th Largest Pharma Company in the US Generics Market
Dermatology Segment
Comprehensive Portfolio
Robust Pipeline
• Largest generic dermatology company and 3rd largest branded
dermatology company in the US
• Wide basket of 599 ANDAS filed & 445 approved ANDAs across
multiple therapies
• 154 ANDAs pending FDA approval, including a combination of
complex generics, FTF opportunities and pure generics
Market Presence
•
Presence in generics, branded & OTC segments
Flexible Manufacturing
Dosage Forms
• Integrated manufacturer with flexibility for manufacturing
onshore/offshore
• Liquids, Creams, Ointments, Gels, Sprays, Injectable, Tablets,
Capsules, Drug-Device combination
© Sun Pharmaceutical Industries Limited. All Rights Reserved.
SUN
PHARMA
* Source: Evaluate Pharma for 12 months ended Dec 2014
17View entire presentation